Diltiazem versus adenosine for treating supraventricular tachycardia in the emergency room

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study compares adults presenting to the emergency department with acute SVT who receive IV adenosine, IV diltiazem, or both, collecting clinical outcomes and patient-reported side effects. Researchers will record treatment success, hemodynamic effects, adverse events, and patients' perceptions of symptom distress after medication. Enrollment is limited to English-speaking adults able to complete surveys and excludes pregnant or incarcerated patients and those too unstable to participate. All study activities occur at the University of Iowa Health Care emergency department.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. ED encounter for acute SVT
2. Age \>/= 18 years
3. Receipt of IV adenosine and/or IV diltiazem for SVT in the ED or prehospital setting

Exclusion Criteria:

1. Neurologic status precluding survey participation due to medical instability
2. Pregnant
3. Incarcerated
4. Non-English speaking

Where it's running

• University of Iowa Health Care
  Iowa City, Iowa, United States Recruiting

Study contacts

• Study coordinator: Anne Zepeski, PharmD
• Email: anne-zepeski@uiowa.edu
• Phone: 651-207-9357

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Adenosine versus diltiazem for stopping SVT in the emergency department

  This pilot will try two IV medicines—adenosine and diltiazem—in adults with acute, stable SVT in the Emergency Department to learn which treatment patients prefer and how they feel afterward.

  Recruiting Phase 4 University of Iowa · Iowa City, Iowa · NCT06993038

• Nasal Swab vs Modified Valsalva for SVT

  This study tests whether a nasal swab can stop SVT as well as the modified Valsalva maneuver in adults who have a confirmed SVT episode.

  Recruiting Marmara University Pendik Training and Research Hospital · Istanbul, Pendik · NCT07617077

• Kardi Ai ECG telemetry monitoring for detecting heart rhythm problems

  The Kardi Ai wearable ECG system will be tested to see if it can accurately detect irregular heart rhythms in adults with or suspected of having heart rhythm disorders.

  Recruiting at 2 sites KARDI AI Technologies s.r.o. · Olomouc, Czechia and 1 other locations · NCT07018648

• Long-term outcomes for patients with cardiac arrhythmias

  This study looks at how well treatments for heart rhythm problems work over time and what factors might affect their success for patients with conditions like atrial fibrillation and ventricular tachycardia.

  Recruiting Universitätsklinikum Hamburg-Eppendorf · Hamburg · NCT05521451

• Mapping the AV node and surrounding areas in patients with tachycardia

  This study is testing a new mapping technique to see if it can help doctors locate the AV node and nearby pathways better in patients with a specific type of fast heart rate called AVNRT.

  Recruiting University Hospital, Toulouse · Toulouse · NCT05296954

• AI-powered ECG to help diagnose and locate tachycardia in patients with PSVT, WPW, PVC, or VT

  A multicenter registry test whether an AI-enabled ECG analysis can help diagnose and localize tachycardia in adults with certain arrhythmias.

  Recruiting Inha University Hospital · Incheon, Incheon · NCT07859020

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.